Conexeu
Manufacturing · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
50 W Liberty St Ste 880, Reno, Nevada, 8...Phone Number
(424) 333-5622Website
www.conexeu.comRevenue
-Stock Symbol
CNXUIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Conexeu
Conexeu is a regenerative medicine company developing CXU, a collagen-based extracellular matrix scaffold medical device candidate designed to support tissue regeneration. Its preclinical platform targets wound care, aesthetics, oral health, animal health, and 3D bioprinting through structural tissue restoration applications.Explore more
Conexeu Org Chart
DB
Co-Founder & Director
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Conexeu your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Conexeu
Check if Conexeu has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Conexeu recently announced quarterly report
Check out if Conexeu is spiking on competitors!
Funding: Get notified immidiatlly once Conexeu has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Conexeu launches new products
Conexeu, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Conexeu had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Conexeu as Masked Content
Find more new buyers
Compare Similar Companies to Conexeu
Compare insights from companies similar to Conexeu, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Conexeu is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Conexeu is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Conexeu.
Conexeu financials insights
Gather financial insights about Conexeu, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$1.3M
2026
Multiple Rounds
$2.7M
Conexeu Tech Stack
A closer look at the technologies used by Conexeu
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Funding
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Conexeu News & Media
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
Board expansion from six to nine directors and the appointment of a Chief Commercial Officer and an advisory board member to help accelerate growth and strengthen execution Board expansion from six to nine directors and the appointment of a Chief Commercial Officer and an advisory board member to help accelerate growth and strengthen executionA Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
Issued on behalf of Conexeu Sciences Inc. Issued on behalf of Conexeu Sciences Inc.Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submissionConexeu Sciences to Ring Nasdaq Bell on June 10, 2026
RENO, Nev., June 03, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, will ring the Nasdaq Closing Bell on Wednesday, June 10, 2026, at the Nasdaq MarketSite in New York City in celebration of its recent public listing and the commencement of trading under the ticker symbol "CNXU."
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Conexeu
Sign Up For FreeTo access detailed company insights
Conexeu is a regenerative medicine company developing CXU, a collagen-based extracellular matrix scaffold medical device candidate designed to support tissue regeneration. Its preclinical platform targets wound care, aesthetics, oral health, animal health, and 3D bioprinting through structural tissue restoration applications.... Read More
